AR002256A1 - ANTI-INFLAMMATORY COMPOSITION, USEFUL FOR OPHTHALOLOGIC AND OTORILARINGOLOGICAL USE - Google Patents
ANTI-INFLAMMATORY COMPOSITION, USEFUL FOR OPHTHALOLOGIC AND OTORILARINGOLOGICAL USEInfo
- Publication number
- AR002256A1 AR002256A1 ARP950100474A AR10047495A AR002256A1 AR 002256 A1 AR002256 A1 AR 002256A1 AR P950100474 A ARP950100474 A AR P950100474A AR 10047495 A AR10047495 A AR 10047495A AR 002256 A1 AR002256 A1 AR 002256A1
- Authority
- AR
- Argentina
- Prior art keywords
- useful
- inflammatory composition
- water
- otorilaringological
- ophthalologic
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Composición anti-inflamatoria, útil para uso oftálmico u otolaringólogico, particularmente nuevas composiciones de suministro de drogas esteroidalesinsolubles en agua, útiles para uso terapéutico. La invención provee además suspensiones acuosasinsolubles en agua útiles para uso terapéutico. Lainvención provee además suspensiones acuosas estables de drogas esteroidales insolubles en agua que tienen tamanos de partículas de l µm que permanecen endicho estado a fin de permitir lasuspensió n inmediata, cuando sea, incluso después de períodos de sedimentación prolongados.Anti-inflammatory composition, useful for ophthalmic or otolaryngological use, particularly new water-soluble steroidal drug delivery compositions, useful for therapeutic use. The invention further provides water-insoluble aqueous suspensions useful for therapeutic use. The invention further provides stable aqueous suspensions of water-insoluble steroidal drugs having particle sizes of 1 µm that remain in this state in order to allow immediate suspension, whenever, even after prolonged periods of sedimentation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP950100474A AR002256A1 (en) | 1995-12-06 | 1995-12-06 | ANTI-INFLAMMATORY COMPOSITION, USEFUL FOR OPHTHALOLOGIC AND OTORILARINGOLOGICAL USE |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP950100474A AR002256A1 (en) | 1995-12-06 | 1995-12-06 | ANTI-INFLAMMATORY COMPOSITION, USEFUL FOR OPHTHALOLOGIC AND OTORILARINGOLOGICAL USE |
Publications (1)
Publication Number | Publication Date |
---|---|
AR002256A1 true AR002256A1 (en) | 1998-03-11 |
Family
ID=37067347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP950100474A AR002256A1 (en) | 1995-12-06 | 1995-12-06 | ANTI-INFLAMMATORY COMPOSITION, USEFUL FOR OPHTHALOLOGIC AND OTORILARINGOLOGICAL USE |
Country Status (1)
Country | Link |
---|---|
AR (1) | AR002256A1 (en) |
-
1995
- 1995-12-06 AR ARP950100474A patent/AR002256A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9407958A (en) | Composition for ophthalmic or otolaryngological anti-inflammatory use | |
ES2187201T3 (en) | USE OF STEROLES AND STEROLESTERS TO NANOESCALA. | |
BR9711856A (en) | Pharmacologically active agents stabilized with protein, methods for their preparation and methods for their use | |
BR9802509A (en) | Use of a copolymer having a suffective or surfactant structure as a dispersing and / or grinding aid. | |
HRP20010463B1 (en) | Controlled release galantamine composition | |
IL161290A0 (en) | Stable composition comprising particles in a frozen aqueous matrix | |
AU2003304237A1 (en) | Gel-stabilized nanoparticulate active agent compositions | |
BR9714015A (en) | Pharmaceutical formulations for prolonged drug delivery | |
CA2345121A1 (en) | Pharmaceutical composition for the treatment of acute disorders | |
AU2155199A (en) | Microparticles for drug delivery across mucosa and the blood-brain barrier | |
HUP0203028A2 (en) | Pharmaceutical formulation containing tolterodine and its use | |
NZ513032A (en) | Non-irritating anti-microbial compostitions | |
BR0109091A (en) | Sustained Release Ranolazine Formulations | |
PT707848E (en) | SOLID PHARMACEUTICAL COMPOSITION COMPREHENDING AN EXCIPIENT CAPACITY TO CONNECT WATER | |
MY135119A (en) | Stabilized oral suspension formulation | |
BR0210630A (en) | Extended release supplier system | |
ES2231176T3 (en) | USE OF BETA- (1,3) -NANOMETRIC GLANES HYDROSOLUBLES. | |
BR0014878A (en) | Pharmaceutical composition containing cyclosonide for mucosal application | |
PT1189595E (en) | Ophthalmic compositions in the form of aqueous oils | |
AU1368497A (en) | New aqueous swellable compositions of guar gum and guar gum derivatives in oleophilic liquids and their use | |
AR002256A1 (en) | ANTI-INFLAMMATORY COMPOSITION, USEFUL FOR OPHTHALOLOGIC AND OTORILARINGOLOGICAL USE | |
BR9811994A (en) | Pharmaceutical suspension comprising nevirapine hemihydrate | |
EE05317B1 (en) | Ethin 1 "Pharmaceutical Composition Containing Stradiol and Drospirenone for Use as a Contraceptive | |
BR0206960A (en) | Oral pharmaceutical composition and use of a hydroxypropyl methylcellulose phthalate polymer | |
AU8387601A (en) | Novel pharmaceutical composition for the topical application of water-insoluble and/or hardly water-soluble active agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |